Interaction of the renin-angiotensin system and the endothelin system in cardiac hypertrophy

Autor: A. C. H. Teisman, Martin Paul, Rainer Dietz, Simone Gschwend, M Stula, W. H. Van Gilst, Michael Böhm, YM Pinto
Přispěvatelé: Other departments
Jazyk: angličtina
Rok vydání: 1998
Předmět:
Zdroj: Scopus-Elsevier
Journal of cardiovascular pharmacology, 31(Suppl. 1), S403-S405. Lippincott Williams and Wilkins
ISSN: 0160-2446
DOI: 10.1097/00005344-199800001-00116
Popis: It has been suggested that the renin-angiotensin system (RAS) interacts with the endothelin system in the pathogenesis of cardiac remodeling. We examined endothelin system regulation in a model of chronic RAS dysfunction, which is believed to be an important factor in cardiac remodeling. We used the transgenic rat line TGR(mRen2)27, which overexpresses the mouse Renin-2 gene and shows hypertension and left ventricular hypertrophy compared to Sprague-Dawley (SD) rats. Ren-2 rats (n = 24) received either losartan (LOS), quniapril (QIN), or carvedilol (CARV) for 11 weeks, or no treatment. After 11 weeks left (LV) and right ventricular (RV) weights were determined and total RNA extracted. Ren-2 rats showed a mean systolic blood pressure of 190 mm (+/- SEM), which could be normalized to 110 +/- mm (+/- SEM) by treatment with LOS or QIN. CARV also reduced blood pressure but did not normalize it. LV end-diastolic pressure was normal in both SD and Ren-2 rats. LV weight was increased in the Ren-2 rats compared to SD rats, and was significantly reduced to normal in the LOS and QIN but not in the CARV group. RV weight was normal in all groups. Northern blot analysis of preproendothelin-1 (preproET-1) and endothelin-converting enzyme-1 (ECE-1) expression revealed a significant (p
Databáze: OpenAIRE